Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Verrica Pharmaceuticals Inc VRCA

Healthcare
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. We are also developing YCANTH for potential... see more

Recent & Breaking News (NDAQ:VRCA)

VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile June 13, 2022

VRCA Investor Update: Robbins LLP Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. (VRCA)

Business Wire June 13, 2022

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Business Wire June 13, 2022

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile June 13, 2022

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

Newsfile June 12, 2022

Stockholder Alert: Robbins LLP Informs Investors of Class Action Against Verrica Pharmacuticals Inc. (VRCA)

Business Wire June 11, 2022

Bronstein, Gewirtz & Grossman, LLC Notifies Verrica Pharmaceuticals Inc. (VRCA) Investors of Class Action and Encourages Investors to Contact the Firm

PR Newswire June 10, 2022

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile June 10, 2022

VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022

PR Newswire June 10, 2022

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

PR Newswire June 9, 2022

Verrica Class Action: Levi & Korsinsky Reminds Verrica Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2022 - VRCA

Newsfile June 9, 2022

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Business Wire June 9, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile June 9, 2022

VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire June 9, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

PR Newswire June 8, 2022

VRCA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Verrica Pharmaceuticals, Inc

Newsfile June 8, 2022

EQUITY ALERT: Rosen Law Firm Encourages Verrica Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

Business Wire June 8, 2022

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals, Inc. (VRCA) Investors

Business Wire June 8, 2022

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors

Business Wire June 8, 2022

Bronstein, Gewirtz & Grossman, LLC Notifies Verrica Pharmaceuticals Inc. (VRCA) Investors of Class Action and Encourages Investors to Contact the Firm

Business Wire June 8, 2022